| Jimmy Walter Lott, MD | |
|
970 Lakeland Dr, Suite 61, Jackson, MS 39216-4635 | |
| (601) 982-7850 | |
| (601) 718-5145 |
| Full Name | Jimmy Walter Lott |
|---|---|
| Gender | Male |
| Speciality | Cardiac Electrophysiology |
| Experience | 38 Years |
| Location | 970 Lakeland Dr, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548206717 | NPI | - | NPPES |
| 00115249 | Medicaid | MS |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Dominic-jackson Memorial Hospital | Jackson, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jackson Heart Clinic. P.a. | 0547204091 | 32 |
News Archive
Expanding on observations made in smaller patient cohorts, researchers studying immune responses of 125 hospitalized COVID-19 patients identified distinct immune profiles - "Immunotypes" - and showed how these signatures correlated with disease severity.
The U.S. Food and Drug Administration today ordered Glenmark Generics of Mahwah, N.J., and Konec Inc. of Tucson, Ariz., to stop marketing unapproved nitroglycerin tablets. The tablets are placed under the tongue to relieve chest pain or to stop a heart attack and are marketed in 0.3 mg, 0.4 mg, and 0.6 mg dosages.
On Wednesday, GlobalPost announced an initiative, dubbed "The GroundTruth Project," which is supported by multiple foundations and includes fellowships for young reporters in "under-reported corners of the world."
A research team at Yale University has found that blocking a kind of cell death called apoptosis in fibrotic diseases of the lung, also blocks the fibrosis, opening new ways of looking at treatment for lung diseases such as pulmonary fibrosis.
Johns Hopkins Institute for Genetic Medicine researchers working as part of the North American Cystic Fibrosis Consortium have discovered two regions of the genome that affect the severity of cystic fibrosis, a genetic condition that causes scarring throughout the body, affecting most notably the pancreas and lungs.
› Verified 7 days ago
| Entity Name | St. Dominic Jackson Memorial |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235173691 PECOS PAC ID: 4385531847 Enrollment ID: O20040301000818 |
News Archive
Expanding on observations made in smaller patient cohorts, researchers studying immune responses of 125 hospitalized COVID-19 patients identified distinct immune profiles - "Immunotypes" - and showed how these signatures correlated with disease severity.
The U.S. Food and Drug Administration today ordered Glenmark Generics of Mahwah, N.J., and Konec Inc. of Tucson, Ariz., to stop marketing unapproved nitroglycerin tablets. The tablets are placed under the tongue to relieve chest pain or to stop a heart attack and are marketed in 0.3 mg, 0.4 mg, and 0.6 mg dosages.
On Wednesday, GlobalPost announced an initiative, dubbed "The GroundTruth Project," which is supported by multiple foundations and includes fellowships for young reporters in "under-reported corners of the world."
A research team at Yale University has found that blocking a kind of cell death called apoptosis in fibrotic diseases of the lung, also blocks the fibrosis, opening new ways of looking at treatment for lung diseases such as pulmonary fibrosis.
Johns Hopkins Institute for Genetic Medicine researchers working as part of the North American Cystic Fibrosis Consortium have discovered two regions of the genome that affect the severity of cystic fibrosis, a genetic condition that causes scarring throughout the body, affecting most notably the pancreas and lungs.
› Verified 7 days ago
| Entity Name | Jackson Heart Clinic. P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659318558 PECOS PAC ID: 0547204091 Enrollment ID: O20050615000346 |
News Archive
Expanding on observations made in smaller patient cohorts, researchers studying immune responses of 125 hospitalized COVID-19 patients identified distinct immune profiles - "Immunotypes" - and showed how these signatures correlated with disease severity.
The U.S. Food and Drug Administration today ordered Glenmark Generics of Mahwah, N.J., and Konec Inc. of Tucson, Ariz., to stop marketing unapproved nitroglycerin tablets. The tablets are placed under the tongue to relieve chest pain or to stop a heart attack and are marketed in 0.3 mg, 0.4 mg, and 0.6 mg dosages.
On Wednesday, GlobalPost announced an initiative, dubbed "The GroundTruth Project," which is supported by multiple foundations and includes fellowships for young reporters in "under-reported corners of the world."
A research team at Yale University has found that blocking a kind of cell death called apoptosis in fibrotic diseases of the lung, also blocks the fibrosis, opening new ways of looking at treatment for lung diseases such as pulmonary fibrosis.
Johns Hopkins Institute for Genetic Medicine researchers working as part of the North American Cystic Fibrosis Consortium have discovered two regions of the genome that affect the severity of cystic fibrosis, a genetic condition that causes scarring throughout the body, affecting most notably the pancreas and lungs.
› Verified 7 days ago
| Entity Name | St. Dominic Medical Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407920549 PECOS PAC ID: 0446303168 Enrollment ID: O20090728000821 |
News Archive
Expanding on observations made in smaller patient cohorts, researchers studying immune responses of 125 hospitalized COVID-19 patients identified distinct immune profiles - "Immunotypes" - and showed how these signatures correlated with disease severity.
The U.S. Food and Drug Administration today ordered Glenmark Generics of Mahwah, N.J., and Konec Inc. of Tucson, Ariz., to stop marketing unapproved nitroglycerin tablets. The tablets are placed under the tongue to relieve chest pain or to stop a heart attack and are marketed in 0.3 mg, 0.4 mg, and 0.6 mg dosages.
On Wednesday, GlobalPost announced an initiative, dubbed "The GroundTruth Project," which is supported by multiple foundations and includes fellowships for young reporters in "under-reported corners of the world."
A research team at Yale University has found that blocking a kind of cell death called apoptosis in fibrotic diseases of the lung, also blocks the fibrosis, opening new ways of looking at treatment for lung diseases such as pulmonary fibrosis.
Johns Hopkins Institute for Genetic Medicine researchers working as part of the North American Cystic Fibrosis Consortium have discovered two regions of the genome that affect the severity of cystic fibrosis, a genetic condition that causes scarring throughout the body, affecting most notably the pancreas and lungs.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jimmy Walter Lott, MD 970 Lakeland Dr, Suite 61, Jackson, MS 39216-4635 Ph: (601) 982-7850 | Jimmy Walter Lott, MD 970 Lakeland Dr, Suite 61, Jackson, MS 39216-4635 Ph: (601) 982-7850 |
News Archive
Expanding on observations made in smaller patient cohorts, researchers studying immune responses of 125 hospitalized COVID-19 patients identified distinct immune profiles - "Immunotypes" - and showed how these signatures correlated with disease severity.
The U.S. Food and Drug Administration today ordered Glenmark Generics of Mahwah, N.J., and Konec Inc. of Tucson, Ariz., to stop marketing unapproved nitroglycerin tablets. The tablets are placed under the tongue to relieve chest pain or to stop a heart attack and are marketed in 0.3 mg, 0.4 mg, and 0.6 mg dosages.
On Wednesday, GlobalPost announced an initiative, dubbed "The GroundTruth Project," which is supported by multiple foundations and includes fellowships for young reporters in "under-reported corners of the world."
A research team at Yale University has found that blocking a kind of cell death called apoptosis in fibrotic diseases of the lung, also blocks the fibrosis, opening new ways of looking at treatment for lung diseases such as pulmonary fibrosis.
Johns Hopkins Institute for Genetic Medicine researchers working as part of the North American Cystic Fibrosis Consortium have discovered two regions of the genome that affect the severity of cystic fibrosis, a genetic condition that causes scarring throughout the body, affecting most notably the pancreas and lungs.
› Verified 7 days ago
Graves Crawley Stubblefield Jr., M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 406 Briarwood Dr, Jackson, MS 39206 Phone: 601-991-1933 Fax: 601-978-3844 | |
Dr. Rebecca Chick Pace, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 N State St, Suite 500, Jackson, MS 39202 Phone: 601-352-2273 Fax: 601-714-3415 | |
Jewelian Akbar Baig, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 971 Lakeland Dr Ste 356, Jackson, MS 39216 Phone: 601-200-4644 Fax: 601-200-4645 | |
Jo P Deal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 766 Lakeland Dr # A, Jackson, MS 39216 Phone: 601-368-3440 Fax: 601-368-3441 | |
Caryl P. Sumrall, FNP Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2500 North State Street, Department Of Medicine/division Of General Internal Med, Jackson, MS 39216 Phone: 601-984-5660 | |
Meghan Alford Luter, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5532 | |
Tammy H Young, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1227 N State St, Ste 101, Jackson, MS 39202 Phone: 601-355-2485 Fax: 601-353-1463 |